Lorcaserin Hydrochloride Powder 616202-92-7 For Weight Loss

Min.Order / FOB Price:Get Latest Price

1 Kilogram	FOB Price:USD 16.0000 -20.0000

1 Kilogram

FOB Price:USD 16.0000 -20.0000

Min.Order :1 Kilogram
Purity: 99%
Payment Terms : L/C,D/P,T/T,,MoneyGram

Keywords

856681-05-5 99% Lorcaserin supplier in China Sell high quility Lorcaserin Hydrochloride 616202-92-7 Lorcaserin 856681-05-5 in China

Quick Details

Appearance:white powder
Application:used in the production of medicine such as miconazole nitrate and yiconazole nitrate
PackAge:As customer request
ProductionCapacity:100|Kilogram|Day
Storage:Store in a cool,dry place and keep away from direct strong light
Transportation:By Sea/Air/Courier

Superiority:

Triumph Chemical Title

Triumph Company Office picture

Triumph Company advantage

Triumph Testing title picture

Triumph Testing way

Welcome to contact us

lorcaserin(616202-92-7) is medicine reducing weight and antidepressants

Details:

lorcaserin(616202-92-7)

Product name: lorcaserin
Cas numbers :616202-92-7
Molecular formula: c11h14cln
Molecular weight 195.6886
Assay 99%
Boiling point 288.125°c at 760 mmhg
Flash point 128.054°c
Appearance white crystal powder
Product usage:medicine reducing weight and antidepressants.

items	standard	results
description	white to kind of white powder	kind of white powder
melting point	193.0-200	196.0-198.9
water	5-6.5%	5.6%
solubility	soluble in methanol	complies
ph	4.0-6.0	5
heavy metals	≤10ppm	complies
assay	≥96%	99.5%
residue on ignition	≤0.1%	0.03%
single impurity	≤0.2%	0.19%
conclusion	up to the standard usp 32.

Obesity has become a worldwide problem since the extra weight can increase the risk of hypertension, diabetes, hyperlipidemia, stroke, heart disease, and osteoarthritis. Lorcaserin(616202-92-7)is an orally administered agent and a selective 5-HT2C receptor agonist for the treatment of obesity. It had been approved for marketing in US by FDA on 27 June in 2012. In clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.

Obesity has become a worldwide problem since the extra weight can increase the risk of hypertension, diabetes, hyperlipidemia, stroke, heart disease, and osteoarthritis. Lorcaserin(856681-05-5)is an orally administered agent and a selective 5-HT2C receptor agonist for the treatment of obesity. It had been approved for marketing in US by FDA on 27 June in 2012. In clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.

View All

Visit Store